Clinical Trial Update: Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [Phase 2]

View source ↗

Summary

Phase 2 safety and tolerability trial of phenylbutyrate in Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: University of Rochester | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED